Gefitinib Completed Phase 2 Trials for Locally Advanced Prostate Cancer Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00319787Combination Casodex® and Iressa™ in Locally Advanced Prostate Cancer